ActualSignal

Company Overview

Snapshot

Founded in September 2023 by Sagi Horev, MD and Hanan Iserovich, ActualSignal operates with 11–50 employees. The company has secured funding across one round from 5 investors, including Tal Ventures, to develop its care management platform.

Business overview

ActualSignal develops an AI-powered care management platform focused on neurology, specifically targeting Parkinson's disease. The company's core technology utilizes unique datasets and artificial intelligence to generate Personal Neurological Profiles, designed to detect early signs of deterioration and admission risks. Serving the healthcare industry, particularly health plans and Accountable Care Organizations (ACOs), ActualSignal's platform is compatible with Value-Based Care infrastructure, aligned with CMS and V28 standards, and supports CPT billing codes for sustainable clinical adoption. The company operates within the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Medical Diagnostics.

Company Intelligence Q&A

What is ActualSignal's primary focus?

ActualSignal focuses on developing an AI-powered care management platform for neurological conditions, specifically Parkinson's disease, to detect early signs of deterioration and admission risks.

When was ActualSignal founded?

ActualSignal was founded in September 2023.

Who are the founders of ActualSignal?

ActualSignal was founded by Sagi Horev, MD and Hanan Iserovich.

Which investors participated in ActualSignal's funding round?

In January 2025, ActualSignal received funding from investors including I-NEXT Capital.

What is the current employee count for ActualSignal?

ActualSignal currently has 11–50 employees.